Transactions

Successful subscription by AOP Health International Management AG of $10m. The Company also announced a RetailBook Offer which raised £96,715.83

Placing and Subscription to raise £11.8m

Placing & Retail Offer raising a total of £12.1m.

Sale of 51% interest in Creo's European subsidiary to Micro-Tech for approximately €36.7m in cash.

Acquisition of Compliance Solutions Lifesciences group for £3.2m in cash and shares alongside a Placing and Retail Offer which raised a total of £5.665m.

Acquisition of IVDeology Holdings Limited for £0.7m in shares.

Placing and Retail Offer raising a total of c. £6.14m

Acquisition of Yourgene Health plc for £16.7m

Placing, Subscription, and Open Offer to raise £33.7m.

Private Placing to raise $20.3m (c. £16.9m)

Placing, Subscription & Open Offer

Consideration for the acquisition is €410,000

The total consideration for the acquisition is €972,500

Completion of the acquisition of Custom Power LLC.

Open Offer and placing raising up to an additional approximately £2m and a subscription raising up to £0.15m

Placing, Subscription and Open Offer of £4.1m

£6m Placing

£2m raised via non pre-emptive cashbox placing

Share Buyback Programme purchasing 9m shares

$30m finance package secured

Aquis IPO and £2.5m fundraise

£10m fundraise

Acquisition of Sanondaf specialist disinfectant business

Open Offer, Placing, Subscription and Primary Bid Offer raising c. £6.5m

£36.32m Placing & Open Offer

Admission to AIM & £17m fundraise

Admission to AIM & £17m fundraise

Admission to AIM & £11.3m fundraise

Acquisition of Attend Anywhere for £16.35m cash

Admission to AIM & £17.5m fundraise

Admission to AIM & £28.5m fundraise

Successful completion of £25.0 million fundraise

£3.4 million placing

Admission to AIM and placing to raise £7.85m at IPO

Acquired by Masimo LHC Limited for £31.1m

Admission to AIM and placing to raise £14.5m at IPO

Acquisition of Boucart Medical SRL for €4.5m

Admission to AIM and placing to raise £35m at IPO

Acquired by Rosen’s Diversified, Inc. for £30.41m

Completion of placing to raise £2.2m

Fundraising to raise gross proceeds up to £11m

Completion of placing, raising £20.5m

Completion of placing to raise £7m

Completion of placing to raise £3m

Placing of £1m and related party transaction

Completion of placing, raising £5.2m

Placing and subscription to raise £1.9m

Completion of placing to raise £5m

Placing and open offer to raise £15m

Admission to the Aquis exchange, raising £515,000

Completion of placing to raise £0.65m

Reverse take-over & IPO on the Main Market of the London Stock Exchange, raising £1.5m

Placing and Open Offer to raise £51.9m

Placing to raise £1.7m

Placing to raise £14m

Acquisition of Tristel Italia srl

Placing to raise £2.1m

Placing and Open Offer to raise £6.0m

Admission to AIM and placing to raise £17m

Admission to AIM and placing to raise £22.25m

Reverse takeover of Sir Martin Sorrell investment vehicle S4 Capital plc

Acquisition of QTS Group for £80m and Placing to raise £45m

Admission to AIM and placing to raise £3m

Acquisition by TT Electronics plc for £45.8m

Admission to AIM and placing to raise £5.5m

Admission to main market and placing to raise £2m

Acquisition of Elemental Healthcare for £9.375m

Admission to AIM and placing to raise £2.25m

Admission to AIM and placing to raise £7.5m

IPO raising £0.8m to form an investment vehicle

IPO raising £3.4m to form an investment vehicle

OptiBiotix Health plc (AIM: OPTI), announces its admission to trading on AIM

ULS Technology Group plc is pleased to announce its admission to trading on AIM